在患有潜在性结肠炎的患者中,莱美环素引起的孤立眼睛史蒂文斯-约翰逊综合征
Christine M Bourke1, Brendan K Cummings2, Daire J Hurley2
1Department of Ophthalmology, Children's Health Ireland at Crumlin, Cooley Road, Crumlin, D12 N512 Dublin, Ireland.
Journal of clinical medicine
|August 26, 2023
概括
史蒂文斯-约翰逊综合征 (SJS) 和有毒表皮解体 (TEN) 可以导致严重的眼睛问题. 这一案例突出显示了一名用Infliximab治疗的性结肠炎患者的罕见,孤立的眼部SJS/TEN呈现,强调了迅速的眼科干预.
科学领域:
- 眼科医生 眼科 眼科
- 皮肤病学 皮肤病学
- 类风湿病学 类风湿病学
背景情况:
- 史蒂文斯-约翰逊综合征 (SJS) 和有毒表皮解体 (TEN) 是严重的粘膜皮肤反应,具有显著的眼部发病率.
- 眼部并发症影响约70%的SJS患者,其中35%的患者经历了慢性后果.
- 用于性结肠炎的infliximab很少与SJS/TEN有关.
研究的目的:
- 报告一个异常情况下的孤立眼部SJS/TEN.
- 讨论非典型SJS/TEN呈现的诊断挑战.
- 突出SJS/TEN中密集眼科管理的重要性.
主要方法:
- 一个患有性结肠炎的患者在Infliximab治疗中的病例报告.
- 诊断工作包括微生物扫描和结膜活检.
- 治疗涉及高剂量静脉注射类固醇和双重免疫抑制.
主要成果:
- 患者呈现出眼部症状的潜伏和非典型发作,造成了诊断困境.
- 结膜活检对于确认诊断至关重要,排除了严重的细菌结膜炎.
- 成功的管理涉及高剂量的静脉注射类固醇和双重免疫抑制.
结论:
- 孤立的眼部SJS/TEN可以呈现异常,即使在诱导剂停止使用后.
- 结膜活检是挑战性病例的关键诊断工具.
- 积极的眼科治疗对于预防SJS/TEN患者的长期视力损失至关重要.
相关概念视频
Drugs for Treatment of Ulcerative Colitis in IBD
173
Ulcerative colitis is a chronic inflammatory condition primarily affecting the colon and rectum. The primary drugs used in the treatment of ulcerative colitis are aminosalicylates. They exhibit anti-inflammatory and immunosuppressive properties. They modulate inflammatory mediators and inhibit the activity of nuclear factor κB (NF-κB). Aminosalicylates also reduce inflammation by inhibiting prostaglandin and leukotriene production and decreasing neutrophil chemotaxis and superoxide...
173
Inflammatory Bowel Disease I: Ulcerative Colitis
215
Introduction
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
215
Drugs for Peptic Ulcer Disease: Sucralfate as Mucosal Protective Agents
556
In the intricate landscape of the gastric lumen, excessive acid secretion disrupts the natural defense mechanisms, weakening the mucus-bicarbonate barrier. This vulnerability allows pepsin to infiltrate epithelial cells, digesting mucosal proteins and triggering erosion, leading to ulcer formation.
In this scenario, mucosal protective agents like sucralfate play an essential role. Sucralfate, a complex of sulfated sucrose and aluminum hydroxide, demonstrates its usefulness in acidic conditions,...
In this scenario, mucosal protective agents like sucralfate play an essential role. Sucralfate, a complex of sulfated sucrose and aluminum hydroxide, demonstrates its usefulness in acidic conditions,...
556
Peptic Ulcer Disease II: Pathophysiology
518
Peptic Ulcer Disease (PUD) is characterized by the development of ulcers in the stomach or duodenal mucosa. Its pathophysiology is complex, involving a balance between damaging and protective elements.
Damaging agents such as Helicobacter pylori, gastric acid, pepsin, and nonsteroidal anti-inflammatory drugs (NSAIDs) can weaken the mucosal defense, allowing hydrogen ions to infiltrate back and harm epithelial cells.
Damaging agents such as Helicobacter pylori, gastric acid, pepsin, and nonsteroidal anti-inflammatory drugs (NSAIDs) can weaken the mucosal defense, allowing hydrogen ions to infiltrate back and harm epithelial cells.
518
Drugs for Treatment of Crohn's Disease in IBD Using Glucocorticoids
150
Glucocorticoids, a class of anti-inflammatory drugs, are pivotal in treating moderate to severe Crohn's disease by inducing remission. They exhibit their anti-inflammatory action by inhibiting the production of inflammatory cytokines such as tumor necrosis factor (TNF)-α, interleukin (IL)-1, and chemokines like IL-8. In addition, they reduce the expression of inflammatory cell adhesion molecules and inhibit gene transcription of nitric oxide synthase, phospholipase A2, cyclooxygenase-2...
150
Treating Helicobacter pylori in Peptic Ulcers: Antimicrobial Therapy
451
Helicobacter pylori, a resilient gram-negative bacterium, can thrive in the stomach's harsh, acidic environment. Infection with H. pylori leads to a cascade of events within the stomach lining. One of the critical disruptions caused by this bacterium is the interference with somatostatin production, a hormone responsible for regulating acid secretion. This interference tips the balance, escalating acid secretion and diminishing bicarbonate levels. This imbalance compromises the defensive...
451


